# The Role of Ga68-PSMA-11 PET Imaging in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy

> **NCT03977610** · NA · COMPLETED · sponsor: **Chang Gung Memorial Hospital** · enrollment: 46 (actual)

## Conditions studied

- Metastatic Prostate Cancer

## Interventions

- **DRUG:** Ga-68 PSMA ligand

## Key facts

- **NCT ID:** NCT03977610
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-01
- **Primary completion:** 2021-07-27
- **Final completion:** 2021-07-27
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2021-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03977610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03977610, "The Role of Ga68-PSMA-11 PET Imaging in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03977610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*